To compare two approaches of interscalene brachial plexus block in arthroscopic shoulder surgery patients

To compare the efficacy of two different approaches of Interscalene Brachial Plexus Block in patients undergoing arthroscopic shoulder surgery.

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2022/04/041580

Enrollment

Registered

2022-04-01

Start date

Unknown

Completion date

Unknown

Last updated

2023-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical Health Condition 2: M244- Recurrent dislocation of joint

Interventions

Intervention1: LOW APPROACH INTERSCALENE BRACHIAL PLEXUS BLOCK: Under USG and PNS guidance, 10mL of 0.5% bupivacaine was injected during low approach of interscalene brachial plexus block. Interventio

Eligibility

Inclusion criteria

Inclusion criteria: 1. Adult patients (18-65 years) of either sex 2. American Society of Anaesthesiology Physical Status ( ASA) Grade I/II with BMI b/w 20-35 kg/m2 3. Patients scheduled to undergo unilateral arthroscopic shoulder surgery 4. Patients can understand and comply with the study instructions

Exclusion criteria

Exclusion criteria: 1. Patients with preexisting obstructive / restrictive lung diseases or preexisting hemi diaphragmatic dysfunction. 2. BMI > 35 kg/metre2 3. History of known local anesthetic allergy 4. History of neurological deficit in upper limbs 5. History of coagulopathy 6. Local site Infection 7. Pregnancy 8. Hepatic/ renal failure

Design outcomes

Primary

Measure	Time frame
To study and compare analgesia following interscalene brachial plexus block (classic Vs low)Timepoint: Baseline, intra-operatively, post block upto 24 hours	—

Secondary

Measure	Time frame
To study and compare incidence of block characteristics (sensory-motor blockade, radiological spread, number of needle passes), respiratory functions, patient satisfaction and complications, if any.Timepoint: Peri-operative monitoring of the block characteristics (sensory-motor blockade, radiological spread, number of needle passes), respiratory functions, patient satisfaction and complications	—

Countries

India

Contacts

Public ContactUdismita Baruah

VMMC and SJH

udismitabaruah@gmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026